Induction of immunological tolerance to islet allografts

A. A. Rossini, David Parker, N. E. Phillips, F. H. Durie, R. J. Noelle, J. P. Mordes, D. L. Greiner

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

T-cell dependent activation of resting B cells involves the interaction of gp39 on T cells with its receptor, CD40, on B cells. We administered either a combination of T-cell-depleted splenic lymphocytes and anti-gp39 monoclonal antibody or antibody alone to establish islet allografts in mice without continuous immunosuppression. Fully allogeneic H-2(q) FVB islets were permanently accepted by chemically diabetic H-2b C57BL/6 mice provided that the recipients were pretreated with both T-cell-depleted donor spleen cells and anti-gp39 antibody. Antibody alone was less effective in prolonging allograft survival, but we did observe that anti-gp39 mAb alone can exert an independent, primary effect on islet allograft survival that was dose dependent. Targeting gp39, in combination with lymphocyte transfusion, might prove suitable for tolerance induction and allotransplantation without immunosuppression.

Original languageEnglish (US)
Pages (from-to)49-52
Number of pages4
JournalCell Transplantation
Volume5
Issue number1
DOIs
StatePublished - 1996
Externally publishedYes

Fingerprint

T-cells
Allografts
Antibodies
T-Lymphocytes
Lymphocytes
Immunosuppression
Lymphocyte Transfusion
B-Lymphocytes
Cells
Monoclonal antibodies
Inbred C57BL Mouse
Cell Communication
Anti-Idiotypic Antibodies
Spleen
Chemical activation
Monoclonal Antibodies

Keywords

  • Allograft
  • CD40
  • CD40 ligand
  • Islet
  • Tolerance

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation

Cite this

Rossini, A. A., Parker, D., Phillips, N. E., Durie, F. H., Noelle, R. J., Mordes, J. P., & Greiner, D. L. (1996). Induction of immunological tolerance to islet allografts. Cell Transplantation, 5(1), 49-52. https://doi.org/10.1016/0963-6897(95)02010-1

Induction of immunological tolerance to islet allografts. / Rossini, A. A.; Parker, David; Phillips, N. E.; Durie, F. H.; Noelle, R. J.; Mordes, J. P.; Greiner, D. L.

In: Cell Transplantation, Vol. 5, No. 1, 1996, p. 49-52.

Research output: Contribution to journalArticle

Rossini, AA, Parker, D, Phillips, NE, Durie, FH, Noelle, RJ, Mordes, JP & Greiner, DL 1996, 'Induction of immunological tolerance to islet allografts', Cell Transplantation, vol. 5, no. 1, pp. 49-52. https://doi.org/10.1016/0963-6897(95)02010-1
Rossini AA, Parker D, Phillips NE, Durie FH, Noelle RJ, Mordes JP et al. Induction of immunological tolerance to islet allografts. Cell Transplantation. 1996;5(1):49-52. https://doi.org/10.1016/0963-6897(95)02010-1
Rossini, A. A. ; Parker, David ; Phillips, N. E. ; Durie, F. H. ; Noelle, R. J. ; Mordes, J. P. ; Greiner, D. L. / Induction of immunological tolerance to islet allografts. In: Cell Transplantation. 1996 ; Vol. 5, No. 1. pp. 49-52.
@article{5713125060d4485cb0da126c8f4633ff,
title = "Induction of immunological tolerance to islet allografts",
abstract = "T-cell dependent activation of resting B cells involves the interaction of gp39 on T cells with its receptor, CD40, on B cells. We administered either a combination of T-cell-depleted splenic lymphocytes and anti-gp39 monoclonal antibody or antibody alone to establish islet allografts in mice without continuous immunosuppression. Fully allogeneic H-2(q) FVB islets were permanently accepted by chemically diabetic H-2b C57BL/6 mice provided that the recipients were pretreated with both T-cell-depleted donor spleen cells and anti-gp39 antibody. Antibody alone was less effective in prolonging allograft survival, but we did observe that anti-gp39 mAb alone can exert an independent, primary effect on islet allograft survival that was dose dependent. Targeting gp39, in combination with lymphocyte transfusion, might prove suitable for tolerance induction and allotransplantation without immunosuppression.",
keywords = "Allograft, CD40, CD40 ligand, Islet, Tolerance",
author = "Rossini, {A. A.} and David Parker and Phillips, {N. E.} and Durie, {F. H.} and Noelle, {R. J.} and Mordes, {J. P.} and Greiner, {D. L.}",
year = "1996",
doi = "10.1016/0963-6897(95)02010-1",
language = "English (US)",
volume = "5",
pages = "49--52",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "1",

}

TY - JOUR

T1 - Induction of immunological tolerance to islet allografts

AU - Rossini, A. A.

AU - Parker, David

AU - Phillips, N. E.

AU - Durie, F. H.

AU - Noelle, R. J.

AU - Mordes, J. P.

AU - Greiner, D. L.

PY - 1996

Y1 - 1996

N2 - T-cell dependent activation of resting B cells involves the interaction of gp39 on T cells with its receptor, CD40, on B cells. We administered either a combination of T-cell-depleted splenic lymphocytes and anti-gp39 monoclonal antibody or antibody alone to establish islet allografts in mice without continuous immunosuppression. Fully allogeneic H-2(q) FVB islets were permanently accepted by chemically diabetic H-2b C57BL/6 mice provided that the recipients were pretreated with both T-cell-depleted donor spleen cells and anti-gp39 antibody. Antibody alone was less effective in prolonging allograft survival, but we did observe that anti-gp39 mAb alone can exert an independent, primary effect on islet allograft survival that was dose dependent. Targeting gp39, in combination with lymphocyte transfusion, might prove suitable for tolerance induction and allotransplantation without immunosuppression.

AB - T-cell dependent activation of resting B cells involves the interaction of gp39 on T cells with its receptor, CD40, on B cells. We administered either a combination of T-cell-depleted splenic lymphocytes and anti-gp39 monoclonal antibody or antibody alone to establish islet allografts in mice without continuous immunosuppression. Fully allogeneic H-2(q) FVB islets were permanently accepted by chemically diabetic H-2b C57BL/6 mice provided that the recipients were pretreated with both T-cell-depleted donor spleen cells and anti-gp39 antibody. Antibody alone was less effective in prolonging allograft survival, but we did observe that anti-gp39 mAb alone can exert an independent, primary effect on islet allograft survival that was dose dependent. Targeting gp39, in combination with lymphocyte transfusion, might prove suitable for tolerance induction and allotransplantation without immunosuppression.

KW - Allograft

KW - CD40

KW - CD40 ligand

KW - Islet

KW - Tolerance

UR - http://www.scopus.com/inward/record.url?scp=0029919866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029919866&partnerID=8YFLogxK

U2 - 10.1016/0963-6897(95)02010-1

DO - 10.1016/0963-6897(95)02010-1

M3 - Article

C2 - 8665076

AN - SCOPUS:0029919866

VL - 5

SP - 49

EP - 52

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 1

ER -